| Literature DB >> 28912681 |
Seung H Jung1, Milene L Brownlow1,2, Matteo Pellegrini3, Ryan Jankord1.
Abstract
Individual susceptibility determines the magnitude of stress effects on cognitive function. The hippocampus, a brain region of memory consolidation, is vulnerable to stressful environments, and the impact of stress on hippocampus may determine individual variability in cognitive performance. Therefore, the purpose of this study was to define the relationship between the divergence in spatial memory performance under chronically unpredictable stress and an associated transcriptomic alternation in hippocampus, the brain region of spatial memory consolidation. Multiple strains of BXD (B6 × D2) recombinant inbred mice went through a 4-week chronic variable stress (CVS) paradigm, and the Morris water maze (MWM) test was conducted during the last week of CVS to assess hippocampal-dependent spatial memory performance and grouped animals into low and high performing groups based on the cognitive performance. Using hippocampal whole transcriptome RNA-sequencing data, differential expression, PANTHER analysis, WGCNA, Ingenuity's upstream regulator analysis in the Ingenuity Pathway Analysis® and phenotype association analysis were conducted. Our data identified multiple genes and pathways that were significantly associated with chronic stress-associated cognitive modification and the divergence in hippocampal dependent memory performance under chronic stress. Biological pathways associated with memory performance following chronic stress included metabolism, neurotransmitter and receptor regulation, immune response and cellular process. The Ingenuity's upstream regulator analysis identified 247 upstream transcriptional regulators from 16 different molecule types. Transcripts predictive of cognitive performance under high stress included genes that are associated with a high occurrence of Alzheimer's and cognitive impairments (e.g., Ncl, Eno1, Scn9a, Slc19a3, Ncstn, Fos, Eif4h, Copa, etc.). Our results show that the variable effects of chronic stress on the hippocampal transcriptome are related to the ability to complete the MWM task and that the modulations of specific pathways are indicative of hippocampal dependent memory performance. Thus, the divergence in spatial memory performance following chronic stress is related to the unique pattern of gene expression within the hippocampus.Entities:
Keywords: PANTHER (Protein Analysis Through Evolutionary Relationships); WGCNA (Weighted Gene Co-expression Network Analyses); alternative splicing; chronic variable stress; contextual memory; spatial learning; upstream regulator analysis; whole transcriptome
Year: 2017 PMID: 28912681 PMCID: PMC5582454 DOI: 10.3389/fnmol.2017.00275
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Figure 1Overview of research design. This research was composed of 3 sub-research categories as shown as boxes with dashed lines. In the category of bioinformatics and data analyses, bioinformatics programs/software and data analyzing methods that used for each step were provided in parentheses. *See Supplementary Figure S1 for detailed information about the data analysis methods.
Figure 2MWM performance data and distribution of normalized gene expression. (A) shows the range of MWM performance of these 28 mice. Based on this distribution, mice were grouped in to high (good cognitive performer, shorter latency to platform) or low (poor cognitive performer, longer latency to platform) MWM performance groups (n = 9/group). A significant difference between the high and low MWM performance groups was detected (B, p < 0.0001). Two-way repeated measure ANOVA also resulted in significant group and days difference (C, p < 0.001 for group and days. post hoc-tests showed significant group difference in each day (**p < 0.001 and *p = 0.002). The average of total distance moved during the 5 MWM testing days was also significantly different between the groups (D, p < 0.0001). No statistical group difference was detected from the total distance moved during the probe trial (E, on the 6th MWM testing days, p = 0.84). The volcano plot (F) shows a distribution of fold changes (log2FC) and −log10(p-values) for normalized-and-filtered genes (16,565 genes). Genes (n = 521) with |r| ≥ 0.5 were represented as red-colored dots.
Figure 3Results of PANTHER pathway database analysis. PANTHER pathway analysis was run with 1250 genes that showed significant group differences and identified 111 pathways figure. The top 30 pathways are listed on the right. For the full index lists of these Panther pathway categories, see Supplementary Table S2.
Functional annotation of genes and 30 most enriched GO biological process terms.
| 1 | Negative regulation of cell projection organization (GO:0031345) | 13 | + | 0.00325 |
| 2 | Negative regulation of neuron projection development (GO:0010977) | 13 | + | 0.00325 |
| 3 | Innate immune response (GO:0045087) | 35 | + | 0.00364 |
| 4 | Cellular response to light stimulus (GO:0071482) | 8 | − | 0.00428 |
| 5 | Cellular response to UV (GO:0034644) | 6 | − | 0.00433 |
| 6 | Activation of cysteine-type endopeptidase activity (GO:0097202) | 11 | − | 0.00444 |
| 7 | Activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919) | 11 | − | 0.00444 |
| 8 | Carbohydrate homeostasis (GO:0033500) | 10 | − | 0.00616 |
| 9 | Glucose homeostasis (GO:0042593) | 10 | − | 0.00616 |
| 10 | Zymogen activation (GO:0031638) | 12 | − | 0.00713 |
| 11 | Negative regulation of developmental growth (GO:0048640) | 8 | + | 0.00815 |
| 12 | Regulation of type I interferon production (GO:0032479) | 4 | + | 0.00844 |
| 13 | Negative regulation of cytokine secretion (GO:0050710) | 5 | − | 0.01160 |
| 14 | Regulation of cell cycle arrest (GO:0071156) | 7 | − | 0.01180 |
| 15 | Positive regulation of programmed cell death (GO:0043068) | 55 | − | 0.01190 |
| 16 | Positive regulation of apoptotic process (GO:0043065) | 55 | − | 0.01190 |
| 17 | Receptor-mediated endocytosis (GO:0006898) | 14 | + | 0.01240 |
| 18 | Negative regulation of hemopoiesis (GO:1903707) | 11 | − | 0.01240 |
| 19 | Regulation of metal ion transport (GO:0010959) | 40 | − | 0.01420 |
| 20 | Negative regulation of nucleic acid-templated transcription (GO:1903507) | 115 | − | 0.01470 |
| 21 | Regulation of potassium ion transport (GO:0043266) | 10 | − | 0.01470 |
| 22 | Cellular response to radiation (GO:0071478) | 12 | − | 0.01620 |
| 23 | Regulation of protein complex disassembly (GO:0043244) | 22 | − | 0.01720 |
| 24 | Regulation of collagen biosynthetic process (GO:0032965) | 3 | − | 0.01750 |
| 25 | Regulation of collagen metabolic process (GO:0010712) | 3 | − | 0.01750 |
| 26 | Neurotrophin TRK receptor signaling pathway (GO:0048011) | 2 | − | 0.01800 |
| 27 | Neurotrophin signaling pathway (GO:0038179) | 2 | − | 0.01800 |
| 28 | Intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332) | 5 | − | 0.01810 |
| 29 | Positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731) | 13 | − | 0.01830 |
| 30 | Regulation of ketone biosynthetic process (GO:0010566) | 4 | + | 0.01830 |
+/− for Over/Under represent as being toward lower/higher MWM1-5 days performance, respectively
Genes in the 15 most enriched GO biological process terms are listed in Supplementary Table .
Functional annotation of genes and 30 greatest number of genes contained in the enriched GO biological process terms.
| 1 | Regulation of molecular function (GO:0065009) | 216 | − | 0.02960 |
| 2 | Regulation of apoptotic process (GO:0042981) | 154 | − | 0.04270 |
| 3 | Negative regulation of macromolecule biosynthetic process (GO:0010558) | 133 | − | 0.02740 |
| 4 | Negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 131 | − | 0.03610 |
| 5 | Negative regulation of cellular macromolecule biosynthetic process (GO:2000113) | 128 | − | 0.03880 |
| 6 | Positive regulation of signal transduction (GO:0009967) | 127 | − | 0.03230 |
| 7 | Negative regulation of RNA metabolic process (GO:0051253) | 120 | − | 0.02280 |
| 8 | Negative regulation of RNA biosynthetic process (GO:1902679) | 117 | − | 0.02190 |
| 9 | Negative regulation of nucleic acid-templated transcription (GO:1903507) | 115 | − | 0.01470 |
| 10 | Negative regulation of transcription, DNA-templated (GO:0045892) | 113 | − | 0.02660 |
| 11 | Negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 65 | − | 0.02260 |
| 12 | Positive regulation of cell death (GO:0010942) | 60 | − | 0.02280 |
| 13 | Regulation of catabolic process (GO:0009894) | 58 | − | 0.02480 |
| 14 | Positive regulation of programmed cell death (GO:0043068) | 55 | − | 0.01190 |
| 15 | Positive regulation of apoptotic process (GO:0043065) | 55 | − | 0.01190 |
| 16 | Regulation of metal ion transport (GO:0010959) | 40 | − | 0.01420 |
| 17 | Innate immune response (GO:0045087) | 35 | + | 0.00364 |
| 18 | Circulatory system process (GO:0003013) | 35 | − | 0.02790 |
| 19 | Blood circulation (GO:0008015) | 34 | − | 0.04510 |
| 20 | Positive regulation of catabolic process (GO:0009896) | 32 | − | 0.04320 |
| 21 | Aromatic compound catabolic process (GO:0019439) | 30 | − | 0.04880 |
| 22 | Cellular response to abiotic stimulus (GO:0071214) | 25 | − | 0.02260 |
| 23 | Regulation of protein complex disassembly (GO:0043244) | 22 | − | 0.01720 |
| 24 | Cell fate commitment (GO:0045165) | 21 | − | 0.03700 |
| 25 | Regulation of microtubule polymerization or depolymerization (GO:0031110) | 21 | − | 0.04500 |
| 26 | Potassium ion transport (GO:0006813) | 20 | − | 0.01960 |
| 27 | Regulation of protein depolymerization (GO:1901879) | 20 | − | 0.02650 |
| 28 | Negative regulation of neuron differentiation (GO:0045665) | 18 | + | 0.04760 |
| 29 | Regulation of microtubule depolymerization (GO:0031114) | 17 | − | 0.02500 |
| 30 | Positive regulation of peptidase activity (GO:0010952) | 16 | − | 0.02170 |
+/− for Over/Under represent as being toward lower/higher MWM1-5 days performance, respectively.
Figure 4Results of Weight Gene Coexpression Network Analysis (WGCNA). (A) shows the clustering dendrogram of genes with dissimilarity based on topological overlap computed by the WGCNA. The original modules and merged modules were colored below the clustering dendrogram. A heatmap created by the WGCNA shows the correlation between the trait MWM performance and each module (B). Pearson r-values are depicted on each heatmap block with p-values in parentheses. The eigengene dendrogram of the meta-module mutual correlative analysis (C) shows how closely the MWM performance was correlated with the modules. The pannal (C) shows that the top 2 closest modules with the MWM performance are the magenta and black modules. However, the same meta-module with the trait of MWM performance is the magenta module only. The network connections among the top 30 connected genes in the top highly correlated magenta module with the mean of MWM1-5days performance were visualized by the VisANT software (D). The plots for magenta module show network connections whose topological overlap is above the threshold of 0.02.
Genes that showed significant correlation with MWM1−5 days Performance (p < 0.050).
| | | |
| 0.70 > | | |
| 0.60 > | | |
| | |
GO-Slim Biological Process Results of Statistical overrepresentation test by the PANTHER with 410 significantly correlated genes (input: genes with EntrezGene ID, p < 0.050, and |r| ≥ 0.5).
| Pteridine-containing compound metabolic process (GO:0042558) | + | 71.77 | 1.38E-02 |
| Glycolysis (GO:0006096) | + | 9.90 | 7.93E-04 |
| Response to abiotic stimulus (GO:0009628) | + | 6.24 | 4.15E-02 |
| Synaptic vesicle exocytosis (GO:0016079) | + | 4.10 | 1.73E-02 |
| Nucleobase-containing compound transport (GO:0015931) | + | 3.36 | 9.72E-03 |
| RNA splicing, via transesterification reactions (GO:0000375) | + | 3.24 | 1.16E-02 |
| RNA splicing (GO:0008380) | + | 3.17 | 1.28E-02 |
| mRNA splicing, via spliceosome (GO:0000398) | + | 3.07 | 5.18E-03 |
| Spermatogenesis (GO:0007283) | + | 2.66 | 2.72E-02 |
| mRNA processing (GO:0006397) | + | 2.64 | 5.38E-03 |
| Phospholipid metabolic process (GO:0006644) | + | 2.43 | 3.92E-02 |
| RNA metabolic process (GO:0016070) | + | 1.4 | 1.43E-02 |
| Nucleobase-containing compound metabolic process (GO:0006139) | + | 1.34 | 8.17E-03 |
| Primary metabolic process (GO:0044238) | + | 1.21 | 7.93E-03 |
| Metabolic process (GO:0008152) | + | 1.15 | 2.09E-02 |
| Unclassified (UNCLASSIFIED) | − | 0.83 | 6.09E-03 |
| Regulation of molecular function (GO:0065009) | − | 0.44 | 8.38E-03 |
| Sensory perception (GO:0007600) | − | 0.34 | 2.36E-02 |
| Regulation of catalytic activity (GO:0050790) | − | 0.32 | 1.37E-03 |
+/− for Over/Under represent as being toward low/high MWM performing group, respectively.
Figure 5Pie charts showing biological processes. PANTHER biological pathway analysis was used with 411 genes that were significantly correlated with the MWM performance (p < 0.050 and |r| ≥ 0.5, Table 1). The 1st order of sub biological processes was drawn as a small pie chart in the center of the main biological process pie chart.
Figure 6The networks identified from the IPA. The network 1 (A) was depicted with 35 molecules. The network of upstream transcriptional regulators identified by the Ingenuity's Upstream Regulator Analysis (B). The regulators that were identified to be associated with learning behaviors were outlined with pink-color.
Top 5 Networks identified by the Ingenuity® Pathway Analysis (IPA).
| 1 | 26s Proteasome, ACKR1, Akt, ARR3, BCR (complex), BTG2, CD3, CDC25A, CITED2, Creb, CTTN, DUSP1, ERK, ERK1/2, FOS, GIPR, Histone h4, ICOSLG/LOC102723996, IgG1, Jnk, KHDRBS1, NFkB (complex), NR4A2, P38 MAPK, PDGF BB, PI3K (complex), SBSN, SIAH2, SPN, STAT5a/b, TCR, TICAM2, TRIB1, WNT6, XBP1 | 36 | 19 |
| 2 | ACOX1, BCL2, Cd33, CD68, CD84, CDK9, CDKN1C, CEBPD, COL4A1, COPA, cytochrome C, DIO1, E2F3, GH1, Growth hormone, IGF1R, IGFBP5, IRS2, LIPE, LONP1, LPL, Mcpt8, MEDAG, MYBL1, MYBL2, NCL, NCSTN, NDUFS2, NIT1, PPM1B, PRKAR1A, PTTG1, RB1, STAG3, TXN | 16 | 10 |
| 3 | ADAMTS1, AGMAT, Cg, CNIH4, CYP17A1, DUSP10, EBI3, F2RL1, FSH, GAD1, GLI1, Histone h3, HMGA2, HPGD, IER3, IGFBP7, IL4, IL11, IMPDH1, KDM5B, KMT2D, LGALS3BP, LMNB1, POLM, PPOX, PTX3, RETN, RPS6KA3, SMARCA4, SNUPN, STAR, TBX15, Tpm4, TRIB1, WDSUB1 | 14 | 9 |
| 4 | BCAR3, CDK11A, DIAPH3, ELK3, ENO1, ERK, ETS1, ETV4, GRHL2, HAS3, INF2, ITGA3, KIF23, LAMA3, MCIDAS, MKRN3, MYH6, MYL9, PERP, PHLDA1, PIK3R3, S100A7, S100A8, SCN9A, SEMA3B, SLC26A1, SLPI, SRF, TLR3, TNFAIP8, TP63, Tpm1, ULBP2, YY1, ZDHHC2 | 14 | 9 |
| 5 | ARAF, ASPM, CAMK4, CAPN10, CBLN4, CCR7, CDK2AP1, CHRNA5, CPLX1, CTHRC1, DDC, DOCK1, EP300, FKBP1B, FOXO1, HNF4A, IKZF5, INSIG1, INTS13, IRS2, KIF1B, LIPE, LYL1, MED1, NKX3-1, NR1I3, NTN1, Proinsulin, RAB3A, RYR2, SERPINB2, SNCA, SREBF1, TAL1, TCF3 | 10 | 7 |
Figure 7Results of alternative splice events for 122 genes listed on Supplementary Table-S1. The pie charts (A) represent exon skipping events for genes with more or equal to 5 events of exon skipping. There is a significant difference in the Exon Skipping Events between the groups (p = 0.043) detected by Fisher's Exact Test. (B) represents data for alternative 3' splice border for genes with more or equal to 3 events of alternative 3' splice borders. There is no significant difference between the groups (p = 0.82) detected by Fisher's Exact Test. (C) shows data for alternative 5' splice border for genes with more or equal to 3 events of alternative 5' splice borders. There is no significant difference between the groups (p = 0.32) detected by Fisher's Exact Test. (D) shows data for intron retention for genes with more or equal to 4 events of intron retention. There is no significant difference between the groups (p = 0.12) detected by Fisher's Exact Test. Each data (N; %) on the figures represent as the number of alternative splicing events and percentiles, respectively.
Figure 8Results of the best subset regression analysis. Four acceptable regression models (A) for mouse MWM1-5days performance were identified and are shown here with a regression line (solid red line) and confidence of fit curves (curved red dot lines). Blue dashed lines are the mean of the MWM performance for the 5 days (MWM1-5 performance). Statistical information for the 4 regression models are shown on (B). Bland-Altman Plots with 18 samples in the low and high groups in addition to 7 additional samples (total n = 25). (C) highlights the center lines represent bias of each model and upper and lower dot lines are 95% upper and lower limits of agreements. (D) shows statistical information of Bland-Altman Plots for acceptable 4 regression models created by the best subset regression analysis.